½s¸¹: HSN-37
¤é´Á: DATE-900613
³ü. SUBSTANCE IDENTIFICATION <<ª«½è½T»{>>
(A) NAME:¦WºÙ: ¼Ì¸£ (CAMPHOR)
(B) SY:§O¦W
(1) 1,7,7-TRIMETHYLBICYCLO(2.2.1)-2-HEPTANONE **PEERREVIEWED**
(2) 1,7,7-TRIMETHYLNORCAMPHOR **PEER REVIEWED**
(3) 2-BORNANONE **PEER REVIEWED**
(4) 2-CAMPHANONE **PEER REVIEWED**
(5) 2-KETO-1,7,7-TRIMETHYLNORCAMPHANE **PEER REVIEWED**
(6) BICYCLO(2.2.1)HEPTAN-2-ONE,1,7,7-TRIMETHYL-**PEERREVIEWED**
(7) CAMPHOR--NATURAL **PEER REVIEWED**
(8) HUILE DE CAMPHRE [FRENCH] **PEER REVIEWED**
(9) KAMPFER [GERMAN] **PEER REVIEWED**
(10) Norcamphor, 1,7,7-trimethyl- **PEER REVIEWED**
(C) MF:¤À¤l¦¡: C10-H16-O
(D) RN: CAS ¤Æ¾Çµù¥U¸¹½X: 76-22-2
(E) SHPN:¥@¬É½Ã¥Í²Õ´¹B¿éª««~¦W/½s¸¹:
UN 2717; ¼Ì¸£, ¤ÑµM©Î¦X¦¨ªº.
¶L. MANUFACTURING/USE INFORMATION <<»s³y¤Î¨Ï¥Î>>
(A) MMFG:»s³y¤èªk
¥i¥Ñ³¡¥÷¼Ì¸£¾ð¸g³q¨T»]ÃH¦Ó±o,¤£¹L¤@¯ë³£¥Ñ£\-ªQªoºëÅܦ¨¼Ì¸£ºë,
Às¸£¤A»Ä, ¦A¨m¤Æ¤Î®ñ¤Æ¦Ó±o.
(B) IMP:¤£¯Âª«
(C) MFS:»s³yªÌ
Lonza Inc, Hq, 17-17 Route 208, Fair Lawn, NJ07410, (201)
794-2400; Specialty Chemicals Division; Production site:
Williamsport, PA17701 [SRI. DIRECTORY CHEM PRODUCERS - USA
"1989, p. 511] **UNREVIEWED**
(D) USE:¥Dn¥Î³~
(1) ¥Î©ó»s³y¶ì½¦; §@¬°àÅÖºû¯À¤ÎîŪº¶ì©Ê¾¯; ¥Î©ó²¡º£¤Îªoº£;
¬µÃÄ, ·Ï¤õ»s³y¤W, »ªo (EMBALMING FLUID);¥Î©ó»s³y²§¤þ,¥Òf,
Âå¾Ç¤W¥Î§@§½³¡§Ü¶Ç¬V¤Î³Â¾K;¥Î©ó¦X¦¨§t¼Ì¸£ªº p-´â×ô, Âíµh¾¯,
¤Î¥iÅܧΪº´Ö½¦.
(2) ÂåÃĤW (Ã~Âå) : ¥~¥Î§@¬°¤îÄo¾¯, §Ü¨ë¿E¾¯¤Î¨¾»G¾¯; (SRP:
±q«e¨Ï¥Î) ¤ºªA§@¬°¿³¾Ä¾¯, ±Æ®ð¾¯.
(3) §@¬°ÅXÂξ¯ (¤×¨ä¥i§í¨î¯}Ãa¦çªAªº¸¿Ãþ); ¤Æ§©«~ªº²Õ¦¨¥÷ (
²æ¤ò¾¯, ¤ú»I, °£¯ä¾¯); §Ü¨ë¿E¾¯; §½³¡³Â¾K¾¯.
(4) ÂåÃĤW: §t¼Ì¸£ªº p-´â×ô¦b¤úÂå¾Ç¤W¥Î¨Ó³B²z¤w·P¬Vªº®ÚºÞ.
(5) ¦³³ø§i«ü¥X±N¤w½Õ¨ýªº¤é¥»¥Õ¦â¼Ì¸£ªo¥Î©ó¤£§t°sºëªº¶¼®Æ¤¤
5.4 ppm, ¯M¯Nªº¹ª«¤¤ 1.6-48 ppm, ¤Î½Õ¨ý«~¤¤ 15 ppm.
(E)<LMFI:¥»¦a»s³y¤Î¶i¤f¼t°Ó> (Local Manufacture & Importer)
(1) NAAD:¼t°Ó¦WºÙ¤Î¦í§}
(2) PROD:²£¶q(¶i¤f¶q)
(a) 1972 ¦~µL¸ê®Æ.
(b) 1975 ¦~µL¸ê®Æ.
(c) 1986 ¦~µL¸ê®Æ.
°Ñ. CHEMICAL & PHYSICAL PROPERTIES <<ª«²z¤Î¤Æ¾Ç©Ê½è>>
(A) COFO:ÃC¦â/©Êª¬:
(1) µL¦â©Î¥Õ¦âµ²´¹Åé¡BÁû²É©ÎªÌµ²´¹ªº¶ôª¬; ©ÎªÌ¬°µL¦â¨ì¥Õ¦â¡B
³z©ú¡B²ÊÁWªº¶ôª¬Åé.
(2) ¥Ñ°sºë¤¤©Ò±o¬°µÙ±Åéµ²´¹; ¿Ä¤Æ¤Î§N«o«á±o¨ì¥ß¤èÅéµ²´¹.
(B) ODOR:¨ý¹D: ªÚ»¥B·|º¯³zªº»¨ý.
(C) TAST:À|¨ý: ²¤W¥B²M²Dªº¨ý¹D.
(D) BP:ªmÂI: 204¢J
(E) MP:º²ÂI: 179.75¢J
(F) MW:¤À¤l¶q: 152.26
(G) CORR:»G»k©Ê:
(H) CTP:Á{¬É·Å«×¤ÎÀ£¤O:
(I) DEN:±K«×¤Î¤ñ«: 0.992 (25¢J/4¢J ®É).
(J) DSC:¸ÑÂ÷±`¼Æ:
(K) OWPC:¨¯¾J»P¤ô¤§¤À°t«Y¼Æ:
(L) PH:pHÈ:
(M) SOL:·»¸Ñ«×:
(N) SPEC:¥úÃЯS©Ê:
(1) §é®g²v(Index of Refraction)¬°1.5462 (20¢J/D);³Ì¤j§l¦¬¥úÃÐ
(°sºë) ¬° 290 NM (log E = 1.48).
(2) ³Ì¤j§l¦¬¥úÃÐ (´â¥é) ¬° 292 NM.
(O) VAP:»]®ðÀ£: 5.24 (ªÅ®ð¬° 1).
(P) VISC:ÂH¸Y«×:
(Q) OCPP:¨ä¥¦©Ê½è:
(1) ¦³®Äªº¬°¬¡©ÊºÒ©Ò§l¦¬.
(2) ¬õ¥~½u: 6049
(3) µµ¥~½u: 90
(4) ®ÖºÏ¦@®¶: 30
(5) ½èÃлö: 912
¸v. SAFETY & HANDLING <<¦w¥þ©Ê¤Î³B²z>>
(A) DOT:·N¥~¨a®`ºò«æ³B²z¤è°w
(1) ¤õ¨a©ÎÃz¬µ:
(a) ¦¹ª«½è¨ã¥i¿U©Ê; ¥i³Q¼ö, ¤õªá, ©Î¤õµK©ÒÂI¿U.
(b) ·|«Ü§Öªº¿U¿N²£¥Í¤õµK. (¼Ì¸£, ¯»¥½).
(2) °·±dªº¦M®`:
(a) ¿U¿N·|²£¥Í¨ã¨ë¿E©Ê¤Î¦³¬rªº®ðÅé.
(b) ²´·ú¤Î¥Ö½§Ä²¤Î¼Ì¸£, ¥i¯à¤Þ°_¨`¶Ë.
(c) ±±¨î¤õ³õ¤õ¶Õªº¤ô, ¤Îµ}ÄÀ¦¹ª«½èªº¤ô, §¡·|³y¦¨¦Ã¬V.
(3) ºò«æ³B²z:
(a) ²¨´²«D¥²n¤Hû, ¹jÂ÷¨ü®`°Ï°ì¤Îªýµ´¨aÅܤJ¤f.
(b) ¯¸¥ß¦b¤W·³B, Á×§K¶i¤J§C³B.
(c) ¿W¥ß©I§l¸Ë¸m (SCBA) ¤Î±Ï¤õû¨¾Å@¦ç¶È¯à´£¨Ñ¦³ªº«OÅ@.
(d) ¥´¹q¸Ü½Ð¨Dºò«æ¨ó§U.
(e) ¦pªG¦Ã¬V¨ì¤ô·½,¥ß§Y³qª¾¦³Ãö·í§½.Àô«O¸p¬rºÞ³B¹q¸Ü:(02)311-6067.
(4) °_¤õ®É:
(a) ¤p¤õ®É: ¥Î°®¦¡¤Æ¾Ç·À¤õ¾¯¡N¨F¤g¡N¤ô¬W, ©Î·À¤õªwªj¨Ó·À¤õ.
(b) ¤j¤õ®É: ¥Î¤ô¬W, ¤ôÃú, ©Î¼Ð·Çªwªj·À¤õ.
(c) ¦b¤£¦M¤Î¤Hûªº±¡ªp¤U, ¾¨³t±q¤õ³õ²¾¥h¸Ë¦³¼Ì¸£ªº®e¾¹.
(d) ¥Î¤ô¼QÅx¼ÉÅS¦b¤õµK¤¤ªº®e¾¹¥|©P, ¨Ï®e¾¹§N«o,¨ì¤õ¶Õ³Q¼³·À«á
¤´»ÝÄ~Äò¼Q¤ô.
(e) »·Â÷¼Ñ¨®.
(f) ¦b¼Ñ¨®ªþªñÄY«µÛ¤õ®É, ¥ÎµL¤Hªº»»±±·À¤õ¸Ë¸m¨Ó·À¤õ, ¦pªG°µ
¤£¨ì, «h°h¥X¤õ³õÅý¤õÄ~Äò¿U¿N.
(g) Áâ¤õ: §Q¥Î°®¨F, Met-L-X ¯»¥½©Î G-1 ¥Û¾¥¯».
(5) Âq¥X©Î¥~º|:
(a) Ãö±¼©Ò¦³¤õ·½, ¦b¥~·¸°Ïµ´¤£¥i¦³¤õªá, ¤õµK, ©Î©â·Ï.
(b) ¤£¥i¸IIJ¼â¥Xª«.
(c) ¤Ö¶q°®Àê¥~¬ªª«¥~¬ª®É: ¥Î°®²bªºÃê¤l±N¨ä©ñ¸m¨ì°®²b¥B°®Àꪺ
®e¾¹¤º, ¨Ã¥B¥[»\, µM«á¦A±N¦¹®e¾¹²¾¨«.
(d) ¤j¶qÂq¥X®É: ¥Î¤ô¼QÀã, ¨Ã¿v³ö¹jÂ÷¥~¬ª°Ï, «Ý«áÄò³B²z.
(6) «æ±Ï±¹¬I:
(a) ±N¨üÃøªÌ²¾¦ÜªÅ®ð·sÂA³B, Ápµ¸ºò«æÂåÀø³æ¦ì.
(b) ¿Æ¥h³Q¦Ã¬Vªº¦çª«¤Î¾c¤l, ¨Ã¥[¥H¹jÂ÷³B²z.
(c) ¤@¥¹²´·ú©Î¥Ö½§±µÄ²¨ì¦¹ª«½è, ¥ß§Y¥Î¤j¶q²M¤ô¨R¬~ 15 ¤ÀÄÁ¥H¤W.
(A')<EMT:ºò«æ³B¸m>
EMLS - LIFE SUPPORT :
¦¹¤jºõ°²³]°ò¥»ªº¥Í©R¤ä«ù±¹¬I¤w¸g¹ê¬I.
(1) EMCE:Á{§É¯gª¬
(a) ºKn: ¼Ì¸£¥i«Ü§Öªº¸g¥Ñ¥Ö½§¡B¸zG¹D¤Î©I§l¹D§l¦¬,
¨ä¥i¦b§]¤J
5 ¤ÀÄÁ¤º, ¨S¦³¥ô¦ó¼xÔªº±¡ªp¤U¬ðµM¤Þ°_¤jµo§@ seizure . ¤p«Ä¦b
§]¤J 5ml ªº¼Ì¸£ªo«á·|¾ÉP¦º¤`.©I§l¤¤¦³¼Ì¸£ªº®ð¨ý, ¦³§U©ó¬O§_¼Ì
¸£¤¤¬rªº¶EÂ_.
´¿¦³³ø§i«ü¥XºC©Ê¼Ì¸£¤¤¬rªºÁ{§Éªí²{»P¹êÅç«Çªºµ²ªG
»P¹p¤ó¯gª¬Reye's syndrome Ãþ¦ü.
(b) ²´¦Õ»ó³ï¤è±:
·|²£¥ÍÀû¤Õ©ñ¤j, ¼v¹³°{Ã{, ÅܶÂ, ©ÎªÌµø½u¼Ò½k¯gª¬¬Ò¥i¯à²£¥Í.
(c) ©I§l¤è±:
¬ðµMµo§@«áªº©I§l§íÆ{¤Î©I§l¼È°±²{¶H¬Ò¥i¯à²£¥Í.
(d) ¯«¸g¤è±:
¬ðµMµo§@¬°¤¤¬rªº¯S¼x. ¯«§Ó¤£²M, ¿³¾Ä, ©ö«ã,¤Î¾Ô奤]±`¨£. ¤£¹L
ºC©Ê¤¤¬r¥i¯à¨S¦³¯«¸g¨t²Î¤è±ªº¯gª¬.
(e) G¸z¤è±:
¤fµÄ¤Î¸¡¤W³¡¨`¶Ë·P, ¤ÏG, ¹Ã¦R, ¬O±`¨£ªº.
(f) ¨xŦ¤è±:
»´«×ªº¤¤¬r·|¨Ï SGOT ¤Î LDH ¤W¤É; ªø´Áªº§]¤J·|²£¥Í¦×ªÞ¸~©Ê¨xª¢.
(2) EMLAB:Á{§ÉÀËÅç
(a) ¹ï¼Ì¸£¨ÃµL¯S©wªº¹êÅç¤ÀªR.
(b) ¼Ì¸£ªº¿@«×¦h¹è¦bÁ{§É¤W¨ÃµL¦h¤j¥Î³B.
(3) EMTR:ªvÀøÂ²¤¶
¤fµÄ¼ÉÅS:
(a) ¤£¥iªA¥Î¶Ê¦R¾¯, ¦]¬°¥i¯à¬ðµMµo¥Í seizures.
(b)
¬¡©ÊºÒ¬°¤@¦³®Ä¥B²×¤î¼Ì¸£¸g¥ÑG³¡³Q§l¦¬ªº¦MÀI©Ê¸û§Cªºª«½è,
°²¦p¯f±w©ü°g¤£¿ô¦Ó®ðºÞ¥i¥H®ðºÞ¤º½¤ªº´¡ºÞ¥[¥H«OÅ@,
¦bªA¥Î¬¡©ÊºÒ
¤§«e¥i¥ý¬~G.
(c) ¬¡©ÊºÒ/¬~G: ªA¥Î¬¡©ÊºÒªdª¬²G(slurry), ¤ô·»²G, ©ÎªÌ»P¬~G²G
²V¦Xªº²V¦X²G©ÎªÌ²M²D¾J¯ù,¤@¯ë¬¡©ÊºÒªº¾¯¶q: ¦¨¤H¬° 30 ¨ì100¤½§J,
«Äµ£¬° 15 ¨ì 30 ¤½§J (À¦¨à¬°¨C¤½¤çÅé« 1 ¨ì 2¤½§J). ªA¥Î¤@Ó¾¯
¶qªº¬~G²G,»P¬¡©ÊºÒ¤@°_¨Ï¥Î©ÎªÌ¤À¶}¨Ï¥Î.ªA¥Î¾¯¶q½Ð°Ñ¦Ò²Ä5.3.1¸`.
(d) SEIZURES: µ¹¤©ÀR¯ßª`®g diazepam, (¾¯¶q: ¦¨¤H: ¶}©l®É5¨ì10mg
, ¥i¨C 15 ¤ÀÄÁ¨Ï¥Î¤@¦¸, ³Ì°ª¤@¦¸¥i¨ì 30 mg. «Äµ£: ¤@¦¸¬°¨C¤½¤çÅé
«µ¹¤© 0.25 ¨ì 0.4 mg, ³Ì°ª¾¯¶q¨ì 10 mg).°²¦pµLªk±±¨î seizures©Î
ªÌ¨ä¦Aµo¥Í«hªA¥Îphenytoin ©ÎªÌ¤Af°ò¤þ¤GñQúE.
(e) °±¤î©I§l: ¥H®ðºÞ´¡ºÞ¤Î¨ó§U©I§lªvÀø.
(4) EMTOX:¬r©Ê½d³ò
(a) P¦º¶q: 1 g §Y¥i¾ÉP¤p«Ä¦º¤`, ¦¨¤H 2 g ¥i¥H²£¥Í¤¤¬r¯gª¬, ¤£
¹L20g¤´¥i¦s¬¡.¼Ì¸£ªo§t¦³20%ªº¼Ì¸£,¬G 5 ml ¼Ì¸£ªo¤¤§t¦³1gªº¼Ì¸£.
(b) ¥Ñ©ó»~À| (©Î»~¹¤p¶q¦p¤@´ö°Íªº) ºû§JµPµ¬°©ªo(Vicks Vaporub)
©ÎÃþ¦üªº²£«~¦Ó²£¥Í¦¸µo©Êªº«æ©Ê¼Ì¸£¤¤¬r«D±`¤Ö¨£.
(c) ¹¤J¼Ì¸£¨ä¶q¶W¹L 35 mg/kg ®É¨ä¨Öµo¯gª¬¥]¬A·w³Ö, µoÖæ, ¦åÀ£§C
, ¤ß«ß¤£¾ã, ¤Îºë¯«ª¬ºAªº§ïÅÜ.
(5) REFERENCE:°Ñ¦Ò
[Rumack BH & Spoerke DG: POISINDEX(R) Information System.
Micromedex Inc., Denver, CO, 1990 ; CCIS CD-ROM Volume 66,
edition exp November , 1990. ]**PEER REVIEWED**
(B)<FLAM:¥i¿U©Ê>
(1) FPOT:¿U¿N¼ç¦b©Ê
¥[¼ö«á·|ÄÀ¥X¥i¿U»]®ð.
(2) NFPA:¦M®`µ¥¯Å
(a) °·±d¦M®`¯Å¼Æ: 0
0 ªí¥Ü¦¹ª«½è§Y¨Ï¼ÉÅS¦b¤õ³õ¤¤, ¨ä²£¥Íªº¦M®`¤]¤£·|¶W¹L¤@¯ëªº¥i¿Uª«.
(b) ¥i¿U©Ê¯Å¼Æ: 2
2 ªí¥Ü¦¹ª«½è¥²¶·¤¤«×¥[¼ö¤~¦³¥i¯à¿U¿N. ¥Î¤ô§Y¥i±N¤õ¼³·À,
¦]¬°¤ô¥i
¨Ï¦¹ª«½è°§C¨ä°{¤õÂI(Flash Point).
(c) ¤ÏÀ³©Ê¯Å¼Æ: 0
0 ªí¥Ü¦¹ª«½è§Y¨Ï¼ÉÅS¦b¤õµK¤¤¥ç«D±`éw , ¥B¤£·|»P¤ô²£¥Í¤ÏÀ³
. ¤@
¯ë·À¤õ±¹¬I§Y¥i¾A¥Î.
(3) FLMT:¥i¿U½d³ò¤U 0.6%; ¤W 3.5%.
(4) FLPT:°{¤õÂI150¢K; 66¢J
(5) AUTO:¦Û¿UÂI871¢K (466¢J)
(C)<FIRE:·À¤õ¸ê®Æ>
(1) FIRP:·À¤õ¤èªkªwªj, ¤G®ñ¤ÆºÒ, °®¦¡¤Æ¾Ç·À¤õ¾¯.
(2) TOXC:¿U¿N«á¬r©Ê²£ª«
(3) OFHZ:¨ä¥¦·À¤õ¦M®`©Ê
(4) EXPL:Ãz¬µ¼ç¦b©Ê¤Î½d³ò
(a) ¼Ì¸£·|»P¤T®ñ¤Æ»Ì°_¼@¯P¤ÏÀ³.
(b) ·í¥[¼ö®É·|ÄÀ¥X¨ãÃz¬µ©Êªº»]®ð.
(D)<HAZR:¦M®`¤ÏÀ³>
(1) REAC:¤ÏÀ³©Ê¤Î¤£¥i¬Û®e©Ê
(2) DCMP:¤À¸Ñ©Ê
(3) POLY:»E¦X©Ê
(4) OHAZ:¨ä¥¦¦M®`¤ÏÀ³
(E)<WRNP:¥Üĵ©Ê½è>
(1) ODRT:¶å¨ý»ÖÈ
(2) SERI:¥Ö½§/²´·ú/©I§l¹D¤§¨ë¿E©Ê
(F)<PRVN:¨¾Å@³B¸m>
(1) EQUP:¨¾Å@³]³Æ
(2) OPRM:¨ä¥¦¨¾Å@¤èªk¤£¥iÀ¹Áô§Î²´Ãè³B²z¦¹ª«½è.
(G) SSL:¦w©w©Ê/¥b¥Í´Á¦b«Ç·Å«ÇÀ£¤U·|ª@µØ.
(H) SHIP:¸Ë¹B(¤èªk¤Î³W©w)
¼Ì¸£·|ÄÀ¥X¥i¿U»]®ð,
¬G¦b¹B¿é®É¥²»Ý¸Ë©ó§¹¥þ¤£³z®ðªº¥]»q©Î½c¤l¸Ì,
¦P®É,
¦b²î¤W¹B¿é®É¥²»ÝÀx¦s©ó³q·¨}¦nªº¦a°Ï¥B»Ý»·Â÷¥ô¦ó¼ö·½¤Î®ñ
¤Æª«½è.
(I) STRG:Àx¦sª¬ªp
(J) CLUP:²M°£¤èªk
(K) DISP:³B¸m¤èªk
¥î. TOXICITY/BIOMEDICAL EFFECTS <<¬r©Ê/¥Í²z¾Ç®ÄÀ³>>
(A) TOXS:¬r©ÊºKn
(B) TXHR:¬r©Ê¦M®`µ¥¯Å
(C) PPOT:¤¤¬r¼ç¦b©Ê
(D) ANTR:¸Ñ¬r»Pºò«æ³B²z
¤@Ó 2 ·³ªº¤p«Ä³Ü¤F¤j¬ù 9.15ml ªº Camphophenique(§t¦³ 10.8%
¼Ì¸£), ¦b»°©¹«æ¶E«Çªº³~¤¤, ®t¤£¦h¤Q¤ÀÄÁ«á, ³o¤p«Ä²£¥Í¤F 4-5
¤ÀÄÁªº±jª½©Ê°}Å˵o§@.¨ì¹F«æ¶E«Ç«á, ¨ä¦åÀ£¬O 100/72 mm Hg,
¯ß·i¬O¨C¤ÀÄÁ 124 ¦¸, ¦Ó¨C¤ÀÄÁ©I§l 24 ¦¸, Åé·Å¬O 37¢J. ³o¤p
«Ä§e°gºÎª¬¨Ã¹ïµhıµL¤ÏÀ³. «æ¶E³B²z¥]¬AÀR¯ßª`®g17 mg/kg ªºf
°ò¤Ú¤ñ§´. ¬~G«á¦Aµ¹¤© 15 gªº¬¡©ÊºÒ.¨ä°Ê¯ß¦åªº»ÄÆP«×¬O7.36,
¨ä PO2 ¬O 110, ¦ÓPCO2 ¬O 36. ¨ä§¹¾ãªº¦å²yp¼Æ, ¹q¸Ñ½è, ¨x
¥\¯à´úÅç, ¦å¤¤®ò§t¶q, ¤Î¯Ý³¡©ñ®g¼v¹³¬Ò¥¿±`, ¦Ó«á«h¨C 12¤p®É
µ¹¤©ÀR¯ßª`®g 30 mg ªºf°ò¤Ú¤ñ§´, ¨äºë¯«ª¬ºA¦b 24 ¤p®É¥H«á¦^
´_¥¿±`ª¬ªp.
(E) MEDS:ÂåÅ@ºÊ·þ
(F) HTOX:¤HÃþ¬r©Ê
(1) ¯gª¬ (¹¤J«á 5 ¦Ü 90 ¤ÀÄÁ):
(a) äú¤ß¤Î¹Ã¦R.
(b) ı±o«Ü·x, ÀYµh.
(c) °g´b, ¯t·w, ¿³¾Ä, ·ÐÀꤣ¦w, ©O³ä, ¤Ûı.
(d) ¦Ù¦×¿³¾Äµ{«×¤W¤É, ¾_Ÿ, ¤Î¤Ï®g©Ê°Ê§@.
(e) Åöíw©ÊÅå³Ö,Ä~¦Ó¦³§íÆ{¯g ¨äÅå³Ö¦³®É«Ü¦´N·|²£¥Í,¦Ó¥Bµ{«×«ÜÄY«.
(f) ©ü°g, ¤¤¼Ï¯«¸g¨t²Î¾÷¯à¤U°«Ü¥i¯à¬O¥DnªºÁ{§É¤ÏÀ³.
(g) ©I§l¥\¯à°IºÜ¤ÎÅöíwª¬ªp¬Ò¥i¾ÉP¦º¤`.
(h) «ì´_«ÜºC (¥i¯à»Ý¼Æ¤Ñ¦Ü¼Æ¬P´Á), ¦Ó¥B±`¦³«ùÄò©ÊªºG¤£µÎªA.
(2) ·í¹¤J¤¤¬r¾¯¶qªº¼Ì¸£«á, ¨ä¥Ö½§·|Åܦ¨Àã§N,
¦ÓÁy¥Ö«h¦³ªx¬õ¤Îªx¥Õ
¥æ´À²{¶H, ¨ä¯ß·iÅÜ®z¦Ó¥B·|Åܱo«Ü¨³³t.
(3) ¦b§t¬rª««~«ü«n (Poisindex) ¤¤¦³¦h©ó 950 ºØªº²£«~§t¦³¼Ì¸£. ¦Ó¦^
ÅU©Ò¦³¹¤J¤j©ó©Îµ¥©ó 2 mg/kg ªº¼Ì¸£®×¨Ò¤¤, ¦³ 73 Ó¯f¤H(90%)¨ÃµL¥ô
¦ó¯gª¬, 3 Ó¯f¤H¯gª¬»´·L(4%), ¦Ó 5 ¦ì±wªÌ(6%) ¨ä¦b¹¤J¶W¹L 59mg/kg
ªº¼Ì¸£«á²£¥ÍÄY«ªº¯gª¬, ¦ý¬O¨ÃµL¦º¤`ªº®×¨Ò.
(G) NTOX:«D¤HÃþ¬r©Ê
¦b¤p¹«µ¹¤©¦h¦¸ªº¼Ì¸£³B²z«áµo²{¦³¯«¸gÃa¦º²{¶H.
(H)<TOXV:¬r©ÊÈ>
(1) HTXV:¤HÃþ¬r©Ê¼Æ¾Ú
(2) NTXV:«D¤HÃþ¬r©Ê¼Æ¾Ú
(3) ETXV:¥ÍºA¬r©Ê¼Æ¾Ú
(4) MINF:³Ì§CP¦º¾¯¶q
(5) POPL:°ª¦MÀI¸s
(6) IARC:¥@¬É½Ã¥Í²Õ´¹ïPÀù©Êªº§PÂ_
(I)<PHMK:ÃĪ«°Ê¤O¾Ç>
(1) ADE:§l¦¬/¤À§G/±Æªn
(a) ¼Ì¸£³z¹LÖß½¤¼h§l¦¬¬O«D±`¨³³tªº,
¦b¹¤J«á´X¤ÀÄÁ§Y¥i¹F¨ì¤¤¬r
ªº¿@«×. ¦Ó¦å²G¤¤ªº¼Ì¸£¥i¸g¥Ñ¨xŦ©Î¦b¯×ªÕ¤¤¦s¿n¦Ó°£¥h.
(b) §l¦¬ªº¼Ì¸£¥Dn¬O¥H®ñ¤ÆºAªº¼Ì¸£¾J(CAMPHOROL)¦b§¿¤¤±Æ¥XÅé¥~,
¦ý¬O¥ç¦³¤p³¡¥÷¥i¥Ñ©I§l, ¦½¤ô¤ÎÁT«K¤¤±Æ¥X.
(2) METB:¥NÁ¤Ψ䲣ª«
¼Ì¸£¬O³¡¥÷®ñ¤Æ, ¦Ó³¡¥÷»P§¿¥Ì»Ä§Î¦¨µ²¦Xª«.
(3) BHL:¥Íª«¥b¥Í´Á
(4) ACTN:§@¥Î¾÷¨î
(5) INTC:»PÃĪ«¤§¥æ¤¬§@¥Î
³°. PHARMACOLOGY <<ÃIJz¾Ç>>
(A) BION:¥ÍÅé»Ý¨D
(B) THER:ªvÀø¥Î³~
Ã~Âå¥ÎÃÄ: §½³¡¨Ï¥Î, ¼Ì¸£¦³®z§Üµß§@¥Î,
·í¨ä¨Ï¥Î¦b¥Ö½§¤W®É¦³µo¬õ
§@¥Î. ¼Ì¸£¬O³\¦hÀ¿¾¯ªº¦@¦P¦¨¥÷.
(C) WARN:ÃΫĵ§Ù
Ã~Âå¥ÎÃÄ: /SRP: ¥H«eªº¥Îªk/¥²¶·¥H¸û²`³Bªº¦Ù¦×ª`®g¤~¯àÁ×§KÁw¸~.
ª`®g®É¥i¥H¤À¶}¦b 2 өΦhÓ³¡¦ìª`®g¥H¹F»Ýnªº¾¯¶q.
(D) IDIO:ÃĪ«¯S²§©Ê
(E) TOLR:ÃĪ«§Ô¨ü©Ê
(F) MXDD:¥ÎÃij̤j¾¯¶q
¬m. ENVIRONMENTAL FATE/EXPOSURE POTENTIAL <<Àô¹Ò¬y§G>>
(A)<POLL:¦Ã¬V·½>
(1) NATS:¦ÛµM¦Ã¬V·½
¥Ñ¼Ì¸£¾ð, ¼Ì(L), ¼Ì¬ìµ¥¤¤°ê, ¥xÆW,¤é¥»ªº²£ª«¤Î¨ä¬ÛÃöªººØÃþ¥i±o.
(2) ARTS:¤H¬°¦Ã¬V·½
(B) FATE:Àô¹Ò¬y§G
(C)<ENVT:Àô¹ÒÂà´«©Ê>
(1) BIOD:¥Íª«¤À¸Ñ©Ê
(2) ABIO:«D¥Íª«¤À¸Ñ©Ê
(D)<ENTP:Àô¹ÒÂಾ©Ê>
(1) BIOC:¥Íª«¿@ÁY
(2) KOC:¤gÄ[§l¦¬¤Î²¾°Ê
(3) VWS:¦Û ¤ô/¤gÄ[ ´§µo©Ê
(E)<ENVC:Àô¹Ò¿@«×>
(1) WATC:¤ôÅé¿@«×
(2) EFFL:©ñ¬y¤ô¿@«×
(3) SEDS:©³ªd/¤gÄ[¿@«×
(4) ATMC:ªÅ®ð¿@«×
(5) FOOD:¹«~´úÈ
(6) PLNT:´Óª«Åé´úÈ
(7) FISH:³½Ãþ/®ü²£´úÈ
(8) ANML:°Êª«Åé´úÈ
(9) MILK:¤û¥¤´úÈ
(10) OEVC:¨ä¥¦Àô¹Ò´úÈ
(F)<HUEX:¤HÃþ¼ÉÅS>
(1) RTEX:¥i¯à¼ÉÅS³~®|
(2) AVDI:¨C¤é¥§¡Äá¤J¶q
(3) PBEX:¥i¯à¼ÉÅSª¬ªp
¦b¥]¸Ë¤u¼t¤¤ªº¼Ì¸£¼ÉÅS´¿³Q°Q½×.
(4) BODY:¤HÅét²ü¶q
®Ã. EXPOSURE STANDARDS & REGULATIONS <<¼ÉÅS¼Ð·Ç¤Î³W©w>>
(A) IDLH:¥ß§Y¦M®`¶q(¿@«×)200 mg/¥ß¤è¤½¤Ø.
(B) ADI:¨C¤é¥i±µ¨üÄá¤J¶q
(C) ATOL:®e³\¶q
(D)<OPL:¾·~¤W¤¹³\¶q>
(1) OSHA:¾·~¦w¥þ»P°·±dºÞ²z§½³W©w
(2) NREC:°ê»Ú¾·~¦w¥þ¤Î°·±d¨ó·|n¨D
(3) TLV:»ÖÈ
TLV: TWA 2 ppm, 12 mg/¥ß¤è¤½¤Ø, µu´Á¼ÉÅS¨î: (STEL) 3 ppm, 19 mg/
¥ß¤è¤½¤Ø (1976).
(4) OOPL:¨ä¥¦Â¾·~©Ê¤¹³\¶q
(E)<OREG:¨ä¥¦¼Ð·Ç»P³W©w>
(1) WSTD:¤ô½è¼Ð·Ç
(2) ASTD:ªÅ®ð¼Ð·Ç
(3) SSTD:¤gÄ[¼Ð·Ç
(F) TSCA:¬rª«ºÞ¨îªk
(G) RCRA:¸ê·½«O¦s¦^¦¬ªk
(H) FIFR:Áp¨¹±þÂÎ,§ÜÅð,·À¹«¥ÎÃĪk
(I) FDA:¹«~ÃĪ«ºÞ²zªk
¨h. MONITORING AND ANALYSIS METHODS <<°»´ú»P¤ÀªRªk>>
(A) SAMP:±Ä¼Ë¤èªk
(B) ALAB:¤ÀªR¤èªk
¼Ì¸£¦b¶å»¤ºªº§t¶q¥i¥H§e¦â¤ÏÀ³´ú©w. 39.064-39.067
¼Ì¸£¥ç¥i¥Î®ð¬Û
¦â¼h¤ÀªR©Î®ð¬Û¤Î²G¬Û¦â¼h¤ÀªR´ú©w.
(C) CLAB:Á{§ÉÀËÅç¤èªk
§Q¥Î½èÃлö¤ÀªR¤ñÁɰʪ«¦å²M¤Î§¿¤¤©Ò§tÃĪ«©Î¨ä¥NÁª«ªº¤èªk¤wµo®i¦¨
¥\.°¨¦å²M¤¤¥[¤J¤Ö¶q¯S©wªºÃĪ«,ª¯¦å²M¤Î§¿²G¦bµ¹¤©diethylcarbamazine
, ´¶¾|¥d¦],phenylbutazone «á¨ú±o. §Q¥Î½èÃлö¦b 2 ¤ÀÄÁ¤º¥i¥H¦P®É
´ú¶q¦å²M¤Î§¿ºé¨ú²G¤¤¦h¹F 50 ºØ¤£¦PªºÃĪ«. ¤j¦hÃĪ«¨ú 1 mul ¼Ð¥»
¨ä°»´ú¤U¤¶©ó ng/ml¤Î mug/ml½d³ò. ¦¹ªk¹ï¦å²M¤Î§¿¤¤ªºÃĪ«¤Î¨ä¥N
Áª«´£¨Ñ¨³³t¦Ó·Ç½Tªº´ú©w¤èªk.
¬B. ADDITIONAL REFERENCES <<¨ä¥¦°Ñ¦Ò¸ê®Æ>>
(A) RPTS:¯S§O³ø§i
Briggs GG et al; Drugs In Pregnancy and Lactation: A Reference
Guide To Fetal and Neonatal Risk (Drugs C); Drugs Preg Lactation
42-100 (1984)
(B) TEST:´ú¸Õª¬ªp
(C) HIST:·N¥~¨Æ¥ó¥v
=============================